Administration of Intravenous Iron Formulations Induces Complement Activation In-Vivo

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01885
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Efficiency of Original Versus Generic Intravenous Iron Formulations in Patients on Haemodialysis

PLoS ONE
Multidisciplinary
2015English

Pharmacokinetics, Toxicities, and Efficacies of Sodium Stibogluconate Formulations After Intravenous Administration in Animals

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2003English

Single Dose Preoperative Administration of Intravenous Iron Corrects Iron Deficiency Anaemia in Colorectal Cancer

Journal of Blood Disorders & Transfusion
2010English

Complement Activation Determines the Therapeutic Activity of Rituximab in Vivo

Journal of Immunology
AllergyImmunology
2003English

Plasma Iron Levels and Urinary Iron Excretion After the Intravenous Administration of Different Iron Preparations*

British Journal of Pharmacology and Chemotherapy
1953English

Activation of the Complement System in Patients With Porphyrias After Irradiation in Vivo.

Journal of Clinical Investigation
Medicine
1984English

In Vivo Gene Transfer via Intravenous Administration of Cationic Lipid–protamine–DNA (LPD) Complexes

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1997English

Anemia of Inflammation (AI) Elevated Serum Hepcidin Level and Therapeutic Intravenous Administration of Iron

Journal of Medical Cases
2013English

Complement Activation in Uveitis.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy